Compare Royal Bank of Canada (RY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Bank of Canada vs Sana Biotechnology Inc — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Royal Bank of Canada is far larger — about 331.3× Sana Biotechnology Inc's market cap, and Royal Bank of Canada pays a 2.42% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| RY | SANA | |
|---|---|---|
Market Cap | $289.51B | $873.84M |
Sector | Financials | Health |
52-Week High | $217.87 | $5.92 |
52-Week Low | $128.46 | $2.68 |
Dividend Yield | 2.42% | — |
Enterprise Value | — | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
